Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: A Report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.
Bazarbachi A, Labopin M, Angelucci E, Gülbas Z, Ozdogu H, Arat M, de Rosa L, Pastano R, Pioltelli P, Montserrat R, Martino M, Ciceri F, Koç Y, Socié G, Blaise D, Herrera C, Chalandon Y, Bernasconi P, Marotta G, Castagna L, McDonald A, Visani G, Carluccio P, Vitek A, Simand C, Afanasyev B, Rösler W, Diez-Martin JL, Nagler A, Brissot E, Giebel S, Mohty M. Bazarbachi A, et al. Among authors: ozdogu h. Biol Blood Marrow Transplant. 2020 May;26(5):936-942. doi: 10.1016/j.bbmt.2020.01.003. Epub 2020 Jan 9. Biol Blood Marrow Transplant. 2020. PMID: 31926364 Free article.
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
Beksac M, Haznedar R, Firatli-Tuglular T, Ozdogu H, Aydogdu I, Konuk N, Sucak G, Kaygusuz I, Karakus S, Kaya E, Ali R, Gulbas Z, Ozet G, Goker H, Undar L. Beksac M, et al. Among authors: ozdogu h. Eur J Haematol. 2011 Jan;86(1):16-22. doi: 10.1111/j.1600-0609.2010.01524.x. Epub 2010 Nov 22. Eur J Haematol. 2011. PMID: 20942865 Clinical Trial.
Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.
Rubio MT, D'Aveni-Piney M, Labopin M, Hamladji RM, Sanz MA, Blaise D, Ozdogu H, Daguindeau E, Richard C, Santarone S, Irrera G, Yakoub-Agha I, Yeshurun M, Diez-Martin JL, Mohty M, Savani BN, Nagler A. Rubio MT, et al. Among authors: ozdogu h. J Hematol Oncol. 2017 Jan 24;10(1):31. doi: 10.1186/s13045-016-0389-4. J Hematol Oncol. 2017. PMID: 28118857 Free PMC article.
Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA).
Tekgündüz E, Arat M, Göker H, Özdoğu H, Kaynar L, Çağırgan S, Erkurt MA, Vural F, Kiki İ, Altuntaş F, Demirkan F; Turkish Society of Apheresis (TSA). Tekgündüz E, et al. Among authors: ozdogu h. Transfus Apher Sci. 2017 Dec;56(6):845-849. doi: 10.1016/j.transci.2017.11.025. Epub 2017 Nov 10. Transfus Apher Sci. 2017. PMID: 29153306
Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT.
Cesaro S, Crocchiolo R, Tridello G, Knelange N, Van Lint MT, Koc Y, Ciceri F, Gülbas Z, Tischer J, Afanasyev B, Bruno B, Castagna L, Blaise D, Mohty M, Irrera G, Diez-Martin JL, Pierelli L, Pioltelli P, Arat M, Delia M, Fagioli F, Ehninger G, Aljurf M, Carella AM, Ozdogu H, Mikulska M, Ljungman P, Nagler A, Styczynski J. Cesaro S, et al. Among authors: ozdogu h. Bone Marrow Transplant. 2018 Apr;53(4):422-430. doi: 10.1038/s41409-017-0016-1. Epub 2018 Jan 12. Bone Marrow Transplant. 2018. PMID: 29330396 Free article.
Effects of two doses of anti-T lymphocyte globulin-Fresenius given after full-match sibling stem cell transplantation in acute myeloblastic leukemia patients who underwent myeloablative fludarabine/busulfan conditioning.
Boga C, Yeral M, Gereklioglu C, Asma S, Maytalman E, Aytan P, Kozanoglu I, Sariturk C, Ozdogu H. Boga C, et al. Among authors: ozdogu h. Hematol Oncol Stem Cell Ther. 2018 Sep;11(3):149-157. doi: 10.1016/j.hemonc.2018.01.004. Epub 2018 Feb 20. Hematol Oncol Stem Cell Ther. 2018. PMID: 29474820 Free article. Clinical Trial.
113 results